Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2008 1
2010 1
2011 2
2012 1
2013 2
2014 3
2015 3
2016 3
2017 3
2018 5
2019 3
2020 5
2021 11
2022 5
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Think of ink: Tattoo pigment masquerading as a breast mass.
Chin S, Cumper M, Thomas A, Wylie E. Chin S, et al. Among authors: thomas a. J Med Imaging Radiat Oncol. 2024 Apr 17. doi: 10.1111/1754-9485.13659. Online ahead of print. J Med Imaging Radiat Oncol. 2024. PMID: 38632859
Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
Oommen AM, Isaac R, Paul B, Weller D, Finkel ML, Thomas A, Ram TS, H R P, Cherian AG, Thomas V, Sadan V, Siva R, Rose A, Marcus TA, Jeyapaul S, K SR, Malini T, N S, Jebaraj P, John NO, Ramesh C, Raj C JJ, Kumar S R, B V B, Dorathy P I, Murali V, N P, K K, Ranjani D P. Oommen AM, et al. Among authors: thomas a. PLoS One. 2024 Apr 5;19(4):e0301385. doi: 10.1371/journal.pone.0301385. eCollection 2024. PLoS One. 2024. PMID: 38578742 Free PMC article. Clinical Trial.
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
John AO, Singh A, Yadav P, Joel A, Thumaty DB, Fibi Ninan K, Georgy JT, Cherian AJ, Thomas S, Thomas A, Thomas V, Peedicayil A, Varghese D, Parthiban R, Ravichandran L, Johnson J, Thomas N, Yadav B, Patricia S, Selvamani B, Abraham D, Paul MJ, Chacko RT, Chapla A. John AO, et al. Among authors: thomas a. Eur J Hum Genet. 2024 Mar 28. doi: 10.1038/s41431-024-01596-w. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38538877
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Bhatla N, Joshi S, Pimple S, Kawade A, Balasubramani L, Thomas A, Suri V, Lalwani S, Uday R, Kamath V, Mandal R, Rajeswar A, Peedicayil A, Poli UR, Banerjee D, Sankaranarayanan R, Basu P, Muwonge R, Gairola S, Dogar V, Rao H, Shaligram U. Sharma H, et al. Among authors: thomas a. Lancet Oncol. 2023 Dec;24(12):1321-1333. doi: 10.1016/S1470-2045(23)00480-1. Epub 2023 Nov 7. Lancet Oncol. 2023. PMID: 37949086 Clinical Trial.
Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India.
Oommen AM, Basu P, Cherian AG, Zomawia E, Manoharan R, Pricilla RA, Viswanathan V, Oldenburg B, Subramanian S, Hawkes D, Saville M, Brotherton JML; SHE-CAN collaborators. Oommen AM, et al. Implement Sci Commun. 2023 Jun 8;4(1):62. doi: 10.1186/s43058-023-00436-0. Implement Sci Commun. 2023. PMID: 37291627 Free PMC article.
The clinico pathological features and survival in serous endometrial cancers.
Datta A, Thomas V, Sebastian A, George R, Thomas A, Ram TS, Daniel S, Reka K, Peedicayil A. Datta A, et al. Among authors: thomas a. Gynecol Oncol Rep. 2023 Apr 28;47:101194. doi: 10.1016/j.gore.2023.101194. eCollection 2023 Jun. Gynecol Oncol Rep. 2023. PMID: 37234700 Free PMC article.
59 results